MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s43018-024-00754-9

Медицинская библиотека · Nature cancer · 2024

Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.

Chapeau Emilie A, Sansregret Laurent, Galli Giorgio G, Chène Patrick, Wartmann Markus, Mourikis Thanos P, Jaaks Patricia, Baltschukat Sabrina, Barbosa Ines A M, Bauer Daniel, Brachmann Saskia M, Delaunay Clara, Estadieu Claire, Faris Jason E, Furet Pascal, Harlfinger Stefanie, Hueber Andreas, Jiménez Núñez Eloísa, Kodack David P, Mandon Emeline, Martin Typhaine, Mesrouze Yannick, Romanet Vincent, Scheufler Clemens, Sellner Holger, Stamm Christelle, Sterker Dario, Tordella Luca, Hofmann Francesco, Soldermann Nicolas, Schmelzle Tobias

СтатьяПеревод пока не подготовлен

Аннотация

The YAP-TEAD protein-protein interaction mediates YAP oncogenic functions downstream of the Hippo pathway. To date, available YAP-TEAD pharmacologic agents bind into the lipid pocket of TEAD, targeting the interaction indirectly via allosteric changes. However, the consequences of a direct pharmacological disruption of the interface between YAP and TEADs remain largely unexplored. Here, we present IAG933 and its analogs as potent first-in-class and selective disruptors of the YAP-TEAD protein-protein interaction with suitable properties to enter clinical trials. Pharmacologic abrogation of the interaction with all four TEAD paralogs resulted in YAP eviction from chromatin and reduced Hippo-mediated transcription and induction of cell death. In vivo, deep tumor regression was observed in Hippo-driven mesothelioma xenografts at tolerated doses in animal models as well as in Hippo-altered cancer models outside mesothelioma. Importantly this also extended to larger tumor indications, such as lung, pancreatic and colorectal cancer, in combination with RTK, KRAS-mutant selective and MAPK inhibitors, leading to more efficacious and durable responses. Clinical evaluation of IAG933 is underway.

Для цитирования: Chapeau Emilie A, Sansregret Laurent, Galli Giorgio G, Chène Patrick, Wartmann Markus, Mourikis Thanos P, Jaaks Patricia, Baltschukat Sabrina, Barbosa Ines A M, Bauer Daniel, Brachmann Saskia M, Delaunay Clara, Estadieu Claire, Faris Jason E, Furet Pascal, Harlfinger Stefanie, Hueber Andreas, Jiménez Núñez Eloísa, Kodack David P, Mandon Emeline, Martin Typhaine, Mesrouze Yannick, Romanet Vincent, Scheufler Clemens, Sellner Holger, Stamm Christelle, Sterker Dario, Tordella Luca, Hofmann Francesco, Soldermann Nicolas, Schmelzle Tobias. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.. Nature cancer. 2024. DOI: 10.1038/s43018-024-00754-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.